Sulfonated Polystyrene Derivatives for Specialized Feline Health Applications

The present invention relates to sulfonated polystyrene derivatives adapted for use in specialized feline health applications, including high-security facilities, disaster relief settings, extreme weather conditions, remote areas, and high-altitude environments.

The original patent disclosed the use of sulfonated polystyrene derivatives for treating and/or preventing cat flu. However, these derivatives may not be suitable for use in specialized environments, such as high-security facilities or disaster relief settings, where the risk of infection is heightened or the availability of medical resources is limited. The present inventive concept addresses this limitation by adapting the sulfonated polystyrene derivatives for use in these specialized environments.

The sulfonated polystyrene derivatives of the present invention are designed to provide effective treatment and/or prevention of cat flu in a variety of specialized environments. In one embodiment, the derivative is used in a high-security animal research facility, where it is administered to subjects in need thereof and isolated from external environmental factors using a secure containment unit. In another embodiment, the derivative is used in a disaster relief setting, where it is administered to subjects in need thereof and provided with a portable shelter for protection. In yet another embodiment, the derivative is used in extreme weather conditions, where it is packaged in a weather-resistant unit to protect it from environmental degradation. In still another embodiment, the derivative is used in a remote or isolated area, where it is administered to subjects in need thereof and monitored remotely using a communication device. In a further embodiment, the derivative is used in a high-altitude environment, where it is administered to subjects in need thereof and supplemented with oxygen.

The present inventive concept is novel and non-obvious over the original patent in that it adapts the sulfonated polystyrene derivatives for use in specialized environments, providing a new and innovative solution for treating and/or preventing cat flu in these environments. The inventive step lies in the recognition of the need for specialized derivatives for these environments and the development of derivatives that meet these needs.

Alternative embodiments of the present inventive concept include the use of different metal cations, different ranges of integers for z and n, and different types of secure containment units, portable shelters, weather-resistant packaging units, communication devices, and supplemental oxygen systems. Variations of the inventive concept may also include the use of different formulations of the sulfonated polystyrene derivative, different routes of administration, and different dosing regimens.

The present inventive concept has significant commercial potential in the animal health industry, particularly in the areas of high-security animal research facilities, disaster relief, and extreme weather conditions. The market for these specialized derivatives is expected to grow as the need for effective treatments and preventatives for cat flu in these environments increases.